司替戊醇
临床资料 | |
---|---|
读音 | stir"i pen' tol |
商品名 | Diacomit |
AHFS/Drugs.com | Monograph |
MedlinePlus | a618069 |
核准状况 |
|
怀孕分级 |
|
给药途径 | By mouth |
ATC码 | |
法律规范状态 | |
法律规范 |
|
识别信息 | |
| |
CAS号 | 137767-55-6 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.051.329 |
化学信息 | |
化学式 | C14H18O3 |
摩尔质量 | 234.30 g·mol−1 |
3D模型(JSmol) | |
| |
|
司替戊醇(英语:Stiripentol,商品名Diacomit)是一种抗惊厥药,用于治疗婴儿严重肌阵挛性癫痫(又称Dravet综合征)[3][4]。
参考文献
- ^ Diacomit 250mg hard capsules - Summary of Product Characteristics (SmPC). (emc). 31 May 2019 [8 November 2020]. (原始内容存档于2020-11-13).
- ^ Diacomit- stiripentol capsule Diacomit- stiripentol powder, for suspension. DailyMed. 15 May 2020 [8 November 2020]. (原始内容存档于2020-08-06).
- ^ 3.0 3.1 Diacomit EPAR. European Medicines Agency. [8 November 2020]. (原始内容存档于2020-11-12). Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ^ Stiripentol Monograph for Professionals. Drugs.com. 31 August 2020 [8 November 2020]. (原始内容存档于2020-10-11).